PAGB Calls Out ‘Partial And Incomplete’ Reports Of UK OTC Cough & Cold Shortages

There are no OTC analgesic supply issues in UK despite higher than normal demand, says consumer heathcare industry association PAGB in response to what it labels “partial and incomplete reporting” in the country's media. HBW Insight looks at NielsenIQ market data for the week ending 7 Janurary to get behind the headlines. 

Plenty of capsules and pills laying on a flag of Great Britain
• Source: Shutterstock

UK consumer healthcare industry association PAGB has denied that there are supply issues in the UK with regards to OTC cough and cold medicines.

More from United Kingdom

More from Europe

Bayer Acquires Cara Care Digestive Health App To Grow Precision Health Business

 
• By 

Bayer Consumer Health snaps up digital therapeutic Cara Care for its Precision Health business with an eye to developing its self-care capabilities.

First UK CBD Novel Food Authorizations Expected In 2025

 
• By 

FSA now aims to send the first recommendations for the authorization of CBD novel food products to UK government ministers in 2025, according to its most recent board meeting. The agency is closely scrutinizing trace THC levels and is planning to ban use of CBD food products by under 18s.

Bayer Drops Plan For EU OTC Antifungal Launch After Poor Trial Results

 
• By 

Bayer Consumer Health shelves European launch of topical OTC onychomycosis treatment under its Canesten brand after a Phase III trial of the product - developed by Sweden's Moberg Pharma - failed to meet its primary endpoint.